Strategizing for Safety from Counterfeit Drugs

On April 6, the Office of the U.S. Trade Representative (USTR) released a summary of negotiations that have taken place since the Anti-Counterfeiting Trade Agreement (ACTA) was introduced in June 2008. Countries from across the world, including the United States, Australia, Canada, the European Union, Japan, Mexico, Morocco, New Zealand, Singapore, South Korea and Switzerland, have joined the ACTA to help governments combat the harmful manufacture and distribution of fake goods, such as counterfeit drugs.

[...]